Biotechnology Stock Doubled This: Fund Bets 1.2M Shares
A large fund snapped up 1.2 million Vir Biotechnology shares as the stock doubled this past year. Here’s how to read ...
Index investing focuses on steady, broad exposure to markets, helping you grow wealth over the long run with reduced complexity and lower costs.
27,799 articlesA large fund snapped up 1.2 million Vir Biotechnology shares as the stock doubled this past year. Here’s how to read ...
As the week nears its end, Thursday often brings a fresh wave of data and earnings that can move markets. This guide ...
SpaceX hit the public markets with an IPO price of $135 per share, signaling a game-changing moment for growth invest...
When lululemon shares dropped after the company cut its annual forecast, it sent a clear message about the market's g...
Investors often ask if selling Tesla to invest in SpaceX could pay off. This guide breaks down the reality, the optio...
SpaceX isn’t publicly traded, but investors still wonder about the idea of a rising SpaceX stock. This guide breaks d...
When a top executive sells nearly 5,000 shares of Alpha and Omega Semiconductor, investors pause. This article breaks...
A look at how a $1,000 stake in McDonald’s versus Starbucks would have evolved over the past decade, with today’s mar...
Gen Z is slowing the pace of career jumps in favor of skill-building and strategic planning, a trend that could redef...
A headline-grabbing lawsuit shines a light on pregnancy rights, workplace duties, and the real financial stakes of wo...
On March 2, Ondas surged on news of a $10 million strategic investment and a World View defense partnership. This art...
A biotech CEO just bought a sizable chunk of his company’s stock. That move sparks questions about conviction, risk, ...